Follow
Mark P. Mattson
Mark P. Mattson
Johns Hopkins University School of Medicine
Verified email at jhmi.edu - Homepage
Title
Cited by
Cited by
Year
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ...
autophagy 17 (1), 1-382, 2021
110292021
Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Aβ and synaptic dysfunction
S Oddo, A Caccamo, JD Shepherd, MP Murphy, TE Golde, R Kayed, ...
Neuron 39 (3), 409-421, 2003
50032003
Pathways towards and away from Alzheimer's disease
MP Mattson
Nature 430 (7000), 631-639, 2004
40382004
beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity
MP Mattson, B Cheng, D Davis, K Bryant, I Lieberburg, RE Rydel
Journal of Neuroscience 12 (2), 376-389, 1992
21411992
Apoptosis in neurodegenerative disorders
MP Mattson
Nature reviews Molecular cell biology 1 (2), 120-130, 2000
20552000
Self-propagating, molecular-level polymorphism in Alzheimer's β-amyloid fibrils
AT Petkova, RD Leapman, Z Guo, WM Yau, MP Mattson, R Tycko
Science 307 (5707), 262-265, 2005
19732005
Fasting: molecular mechanisms and clinical applications
VD Longo, MP Mattson
Cell metabolism 19 (2), 181-192, 2014
17582014
Hormesis defined
MP Mattson
Ageing research reviews 7 (1), 1-7, 2008
1743*2008
A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease.
K Hensley, JM Carney, MP Mattson, M Aksenova, M Harris, JF Wu, ...
Proceedings of the National Academy of Sciences 91 (8), 3270-3274, 1994
15481994
Effects of intermittent fasting on health, aging, and disease
R De Cabo, MP Mattson
New England Journal of Medicine 381 (26), 2541-2551, 2019
14942019
Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives
MP Mattson
Physiological reviews 77 (4), 1081-1132, 1997
14021997
Impact of intermittent fasting on health and disease processes
MP Mattson, VD Longo, M Harvie
Ageing research reviews 39, 46-58, 2017
13492017
Mitophagy inhibits amyloid-β and tau pathology and reverses cognitive deficits in models of Alzheimer’s disease
EF Fang, Y Hou, K Palikaras, BA Adriaanse, JS Kerr, B Yang, S Lautrup, ...
Nature neuroscience 22 (3), 401-412, 2019
13122019
Ageing and neuronal vulnerability
MP Mattson, T Magnus
Nature reviews neuroscience 7 (4), 278-294, 2006
13102006
Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease
RG Cutler, J Kelly, K Storie, WA Pedersen, A Tammara, K Hatanpaa, ...
Proceedings of the National Academy of Sciences 101 (7), 2070-2075, 2004
12972004
Lipid peroxidation and protein oxidation in Alzheimer’s disease brain: potential causes and consequences involving amyloid β-peptide-associated free radical oxidative stress
DA Butterfield, CM Lauderback
Free Radical Biology and Medicine 32 (11), 1050-1060, 2002
12732002
BDNF and 5-HT: a dynamic duo in age-related neuronal plasticity and neurodegenerative disorders
MP Mattson, S Maudsley, B Martin
Trends in neurosciences 27 (10), 589-594, 2004
12622004
Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors
AJ Bruce, W Boling, MS Kindy, J Peschon, PJ Kraemer, MK Carpenter, ...
Nature medicine 2 (7), 788-794, 1996
12301996
Evidence that brain‐derived neurotrophic factor is required for basal neurogenesis and mediates, in part, the enhancement of neurogenesis by dietary restriction in the …
J Lee, W Duan, MP Mattson
Journal of neurochemistry 82 (6), 1367-1375, 2002
12002002
NF-κB in neuronal plasticity and neurodegenerative disorders
MP Mattson, S Camandola
The Journal of clinical investigation 107 (3), 247-254, 2001
11812001
The system can't perform the operation now. Try again later.
Articles 1–20